30 TECHNOLOGY: UNLOCKING AND DELIVERING THE POTENTIAL OF THERAPEUTIC NITRIC OXIDE
£5mn funding to develop new treatments for multi-drug resistant tuberculosis
Phase II clinical trial approved for the treatment of chronic infection in patients with cystic fibrosis
NEW MULTICENTRE CLINICAL TRIAL APPROVED TO PREVENT TRANSMISSION OF COVID-19
Scroll Down
30 TECHNOLOGY is developing and defining new models of care by unlocking the potential of Nitric Oxide to treat a host of serious medical conditions.
30 TECHNOLOGY Therapeutic Nitric Oxide